Beximco Pharmaceuticals (DHA:BXPHARMA) Short-Term Capital Lease Obligation : BDT0 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Short-Term Capital Lease Obligation?

Beximco Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was BDT0 Mil.

Beximco Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Jun. 2023 (BDT147 Mil) to Dec. 2023 (BDT0 Mil) but then stayed the same from Dec. 2023 (BDT0 Mil) to Mar. 2024 (BDT0 Mil).

Beximco Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (BDT114 Mil) to Jun. 2022 (BDT161 Mil) but then declined from Jun. 2022 (BDT161 Mil) to Jun. 2023 (BDT147 Mil).

Beximco Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Beximco Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Short-Term Capital Lease Obligation Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

165.77

108.12

113.98

160.58

146.52

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	146.52	-	-

Beximco Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Beximco Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines